MIMS is the Editorial Contents Provider for Singapore’s NDF Initiative
- Written by Telegraph Magazine
SINGAPORE - Media OutReach - 25 July 2022 - MIMS, the region's leading healthcare data and medical knowledge provider, is proud to announce that MIMS has successfully collaborated with Singapore's Ministry of Health (MOH) on the editorial contents for the National Drug Formulary (NDF) website.
The NDF is a MOH initiative under the National Pharmacy Strategy and the website is currently live at www.ndf.gov.sg.
The NDF website aims to establish a Singapore-specific, authoritative and national reference to guide evidence-based best practices for medication prescribing, dispensing, administration and monitoring by consolidating local clinical and drug-related information. NDF provides drug and post-marketing information from the Health Sciences Authority (HSA), subsidy information and drug guidance from the Agency for Care Effectiveness (ACE) and, general availability information from all of Singapore's public healthcare institutions. MIMS, with its team of clinical editors, worked closely with MOH to organize and curate all these information for the NDF website within the stipulated timeframe.
"We at MIMS have been working to empower healthcare communities through our in-house products and services. The NDF website is an important initiative in Singapore's healthcare landscape and is in line with our vision and mission.," said Masaki Takahata, Chief Executive Officer of MIMS Group.
The Project Lead and Editorial Director at MIMS, Leong Wai Fun said, "We are delighted to have been an editorial partner, contributing to the content curation of NDF and enabling healthcare professionals to select safe and effective medicines for patients in Singapore."
We look forward to such partnerships in the region and support clinicians in improving patient outcomes.
Hashtag: #MIMS
About MIMS
MIMS Group, a subsidiary of SMS Co. Ltd. (TYO 2175), has been offering diverse expertise for over 50 years in 17 countries and regions in Asia, Oceania and the Middle East with a focus on providing marketing support services to pharmaceutical companies, clinical decision support tools integrated in healthcare institutions as well as services to empower healthcare professionals in their daily operations. MIMS marketing platform services is spread across 10 countries mainly in South East Asia and has over 2.5 million healthcare professionals registered on the our online platform ( www.mims.com), with drug directory services, medical communications, as well as media platform businesses.
MIMS has offices in the following countries & regions:
Singapore (Headquarters), Australia, China, Hong Kong SAR (China), Indonesia, India, Ireland, Japan, Korea, Malaysia, Myanmar, New Zealand, Philippines, Taiwan (China), Thailand, United Arab Emirates, and Vietnam.
For more information, please visit https://corporate.mims.com